Galectin Therapeutics (GALT) Files 2M Share Stock Shelf for Selling Shareholders

August 16, 2016 8:54 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Galectin Therapeutics (Nasdaq: GALT) filed a registration with the U.S. SEC to sell up to 2 million shares of common stock on behalf of selling shareholders.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment